PT. Daewoong Biologics Indonesia (DBI), a subsidiary of Daewoong Group, specializes in the production of stem cell and cosmetic products. DBI is one of the subsidiaries of Daewoong Pharmaceuticals Company Indonesia, focusing on the development of regenerative medicine in Indonesia and worldwide. PT. DBI was established in September 2021, located in Cikarang (the total area of 10,656㎡), an industrial area in Jababeka. PT. DBI aims to focus on its business on stem cells and cosmeceuticals. The mission of PT. DBI is to research, develop, and locally produce stem cell therapies, personalized medicines, cosmetics, and more. Our vision is to become the leading stem cell and cosmetics company in Indonesia.